Nasus Pharma is trading 5.4% up now at $3.50 after rebounding from the August 5 close of $3.32.
- Available coverage does not identify a new company-specific announcement on August 6, 2026.
- The latest company filing located was the July 28 CEO appointment.
- Healthcare is stronger, providing supportive sector sentiment, but not enough to establish causation.